Accessibility Menu
Invacare logo

Invacare(NYSE) IVC

This security has been delisted. This page is retained for historical reference.

Invacare last closing stock price
MetricPriceDate
Last closeUSD 0.012023-05-05
Invacare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.6%USD 0.022023-04-28
1 month-10%USD 0.022023-04-05
3 month-62.6%USD 0.042023-02-03
Year to date-96.79%USD 0.422022-12-30
1 year-99.15%USD 1.592022-05-05
3 year-99.81%USD 7.172020-05-05
5 year-99.93%USD 18.302018-05-04
Since inception-99.11%USD 1.521984-12-18

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

IVC Financials

Key Financial Metrics (TTM)

Gross Margin

23.65%

Operating Margin

-9.37%

Net Income Margin

-13.63%

Return on Equity

-46.11%

Return on Capital

-12.46%

Return on Assets

-13.11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$171.51M

Operating Income

-$83.99M

EBITDA

-$51.77M

Operating Cash Flow

-$58.17M

Capital Expenditure

-$3.63M

Free Cash Flow

-$61.79M

Cash & ST Invst.

$66.28M

Total Debt

$275.62M

Invacare Performance Analysis

Invacare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 873,515,000N/A
20222022-12-31USD 741,596,000-15.1%
Invacare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-30-6.0%
Q32022-09-30-9.8%
Q42022-12-316.4%
Q12023-03-31-8.7%
Invacare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -1.31N/A
20222022-12-31USD -2.77111.8%
Invacare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-3010.3%
Q32022-09-30-49.2%
Q42022-12-3138.5%
Q12023-03-31-92.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$165.48M

-17.7%

Gross Profit

$43.84M

-8.1%

Gross Margin

26.49%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

3,000

N/A

Net Income

-$41.18M

-70.2%

EBITDA

-$9.97M

+22.4%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$66.28M

+26.6%

Total Debt

$275.62M

-29.2%

Accounts Receivable

$82.66M

-22.3%

Inventory

$103.64M

-29.7%

Long Term Debt

$232.66M

-47.7%

Short Term Debt

$42.96M

+330.4%

Return on Assets

-13.11%

N/A

Return on Invested Capital

-12.61%

N/A

Free Cash Flow

-$32.59M

-9.3%

Operating Cash Flow

-$30.61M

-10.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ELUTElutia Inc
$0.87+0.59%
SDCCQSmileDirectClub Inc Class A
$0.00+0.00%
AKUAkumin Inc.
$0.29-17.87%
ANPCAnPac Bio-Medical Science Co., Ltd.
$4.30-3.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.